Nickson Philip, Chief Business and Legal Officer at Monte Rosa Therapeutics ($GLUE), made one open market sale of common shares in the last 365 days, totaling $47,861. His most recent insider sale occurred on January 5, 2026. Among 11,678 insiders with sales, his amount ranks 10,438th, well below the average of $8.6 million and 6.4 transactions per person. Nickson Philip reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Monte Rosa Therapeutics, Inc. | $GLUE | Nickson Philip | Chief Business & Legal Officer | A | Stock Option (Right to Buy) | 126000 | $0.00 | 126,000.0000 | 82,942,723 | 9999.99% | 0.15% |
| Jan. 2, 2026 | Monte Rosa Therapeutics, Inc. | $GLUE | Nickson Philip | Chief Business & Legal Officer | A | Common Stock | 28000 | $0.00 | 64,000.0000 | 82,942,723 | 77.78% | 0.03% |
| Jan. 5, 2026 | Monte Rosa Therapeutics, Inc. | $GLUE | Nickson Philip | Chief Business & Legal Officer | S | Common Stock | 3155 | $15.17 | 60,845.0000 | 82,942,723 | 4.93% | 0.00% |
| Jan. 2, 2025 | Monte Rosa Therapeutics, Inc. | $GLUE | Nickson Philip | Chief Business & Legal Officer | A | Stock Option (Right to Buy) | 161000 | $0.00 | 161,000.0000 | 73,910,026 | 9999.99% | 0.22% |
| Jan. 2, 2025 | Monte Rosa Therapeutics, Inc. | $GLUE | Nickson Philip | Chief Business & Legal Officer | A | Common Stock | 36000 | $0.00 | 36,000.0000 | 73,910,026 | 9999.99% | 0.05% |
| June 3, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Nickson Philip | Chief Business & Legal Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 51,396,961 | 9999.99% | 0.08% |
| Jan. 2, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Nickson Philip | General Counsel | A | Stock Option (Right to Buy) | 109000 | $0.00 | 109,000.0000 | 51,396,961 | 9999.99% | 0.21% |